4Cotterill SJ,Pearson AD,Pritchard J,et al.Clinical prognostic factors in 1 277 patients with neuroblastoma:results of The European Neuroblastoma Study Group 'Survey' 1982-1992.Eur J Cancer,2000,36(7):901-908
5Handgretinger R,Lang P,Ihm K,et al.Isolation and transplantation of highly purified autologous peripheral CD34(+) progenitor cells:purging efficacy,hematopoietic reconstitution and long-term outcome in children with high-risk neuroblastoma.Bone Marrow Transplant,2002,29(9):731-736
6Donovan J,Temel J,Zuckerman A,et al.CD34 selection as a stem cell purging strategy for neuroblastoma:preclinical and clinical studies.Med Pediatr Oncol,2000,35(6):677-682
7Castel V,García-Miguel P,Canete A,et al.Prospective evaluation of the International Neuroblastoma Staging System (INSS) and the International Neuroblastoma Response Criteria (INRC) in a multicentre setting.Eur J Cancer,1999,35(4):606-611
8Imaizumi M,Watanabe A,Kikuta A,et al.Improved survival of children with advanced neuroblastoma treated by intensified therapy including myeloablative chemotherapy with stem cell transplantation:a retrospective analysis from the Tohoku Neuroblastoma Study Group.Tohoku J Exp Med,2001,195(2):73-83
9Matthay KK,Villablanca JG,Seeger RC,et al.Treatment of high-risk neuroblastoma with intensive chemotherapy,radiotherapy,autologous bone marrow transplantation,and 13-cis-retinoic acid.Children's Cancer Group.N Engl J Med,1999,341(16):1165-1173
10Park JR,Villablanca JG,London WB,et al.Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid:a report from the Children's Oncology Group.Pediatr Blood Cancer,2009,52(1):44-50
